Resolvin D1, but not resolvin E1, transactivates the epidermal growth factor receptor to increase intracellular calcium and glycoconjugate secretion in rat and human conjunctival goblet cells
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Experimental Eye Research
- Vol. 180, 53-62
Abstract
No abstract availableKeywords
Funding Information
- The Norwegian Research Council (EY019470)
- National Institute of Health (R01GM038765)
This publication has 39 references indexed in Scilit:
- Lipoxin A4 Counter-regulates Histamine-stimulated Glycoconjugate Secretion in Conjunctival Goblet CellsScientific Reports, 2016
- Lipoxin A4 activates ALX/FPR2 receptor to regulate conjunctival goblet cell secretionMucosal Immunology, 2016
- Economic and Humanistic Burden of Dry Eye Disease in Europe, North America, and Asia: A Systematic Literature ReviewThe Ocular Surface, 2016
- Ocular Adverse Events Associated with Antibody–Drug Conjugates in Human Clinical TrialsJournal of Ocular Pharmacology and Therapeutics, 2015
- Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretionMucosal Immunology, 2013
- Signaling pathways used by EGF to stimulate conjunctival goblet cell secretionExperimental Eye Research, 2012
- EGF Stimulates Lipoxin A4 Synthesis and Modulates Repair in Corneal Epithelial Cells through ERK and p38 ActivationInvestigative Ophthalmology & Visual Science, 2011
- CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylationRespiratory Research, 2006
- Control of mucin production by ocular surface epithelial cellsExperimental Eye Research, 2004
- Results of a Population-Based Questionnaire on the Symptoms and Lifestyles Associated with Dry EyeCornea, 1999